 | • レポートコード：B-GIR09D2952 • 出版社/出版日：GlobalInfoResearch / 2019年9月11日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、120ページ • 納品方法：Eメール • 産業分類：医薬品・ヘルスケア |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、網膜医薬品の世界市場について調べ、まとめました。種類別セグメントは、黄斑変性症、糖尿病性眼疾患、網膜剥離、網膜芽細胞腫、黄斑斑、黄斑円孔、その他等、用途別セグメントは、病院薬局、オンライン薬局、独立薬局等に区分しました。網膜医薬品の世界市場概観、メーカー動向、メーカー別網膜医薬品シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・網膜医薬品の市場概観 ・網膜医薬品の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・網膜医薬品の企業別販売動向、市場シェア、市場集中度、競争動向 ・網膜医薬品の世界市場規模 ・網膜医薬品の北米市場分析（アメリカ、カナダ、メキシコ等） ・網膜医薬品のアメリカ市場規模推移 ・網膜医薬品のカナダ市場規模推移 ・網膜医薬品のメキシコ市場規模推移 ・網膜医薬品のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・網膜医薬品のドイツ市場規模推移 ・網膜医薬品のイギリス市場規模推移 ・網膜医薬品のロシア市場規模推移 ・網膜医薬品のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・網膜医薬品の日本市場規模推移 ・網膜医薬品の中国市場規模推移 ・網膜医薬品の韓国市場規模推移 ・網膜医薬品のインド市場規模推移 ・網膜医薬品の東南アジア市場規模推移 ・網膜医薬品の南米市場分析（ブラジル、アルゼンチン等） ・網膜医薬品の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・網膜医薬品の種類別分析/販売量、売上、市場シェア（黄斑変性症、糖尿病性眼疾患、網膜剥離、網膜芽細胞腫、黄斑斑、黄斑円孔、その他） ・網膜医薬品の用途別分析/市場規模（病院薬局、オンライン薬局、独立薬局） ・網膜医薬品の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・網膜医薬品の販売チャネル・代理店・貿易業者・ディーラー分析 |
Retinal Pharmaceuticals is primarily used to treat retinal-related diseases.
Retina is a layer of nerve tissue lining the back of the eye. Retina receives light and convert it into neural signals, and send these signals to the brain for visual recognition. The central part of the retina is known as macula, which is responsible for central vision. The remaining tissue outside the macula is responsible for peripheral vision. There are many types of retinal diseases.
Scope of the Report:
The worldwide market for Retinal Pharmaceuticals is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Retinal Pharmaceuticals in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Santen Pharmaceutical Co.，Ltd.
Regeneron Pharmaceuticals，Inc.
Shire Plc
Bayer AG
Novartis International AG
Valeant Pharmaceuticals International，Inc
Merck＆Co.
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Macular Degeneration
Diabetic Eye Disease
Retinal Detachment
Retinoblastoma
Macular Pucker
Macular Hole
Others
Market Segment by Applications, can be divided into
Hospital Pharmacies
Online Pharmacies
Independent Pharmacies
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Retinal Pharmaceuticals product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Retinal Pharmaceuticals, with price, sales, revenue and global market share of Retinal Pharmaceuticals in 2017 and 2018.
Chapter 3, the Retinal Pharmaceuticals competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Retinal Pharmaceuticals breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Retinal Pharmaceuticals market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Retinal Pharmaceuticals sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Retinal Pharmaceuticals Introduction
1.2 Market Analysis by Type
1.2.1 Macular Degeneration
1.2.2 Diabetic Eye Disease
1.2.3 Retinal Detachment
1.2.4 Retinoblastoma
1.2.5 Macular Pucker
1.2.6 Macular Hole
1.2.7 Others
1.3 Market Analysis by Applications
1.3.1 Hospital Pharmacies
1.3.2 Online Pharmacies
1.3.3 Independent Pharmacies
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Santen Pharmaceutical Co.，Ltd.
2.1.1 Business Overview
2.1.2 Retinal Pharmaceuticals Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Santen Pharmaceutical Co.，Ltd. Retinal Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Regeneron Pharmaceuticals，Inc.
2.2.1 Business Overview
2.2.2 Retinal Pharmaceuticals Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Regeneron Pharmaceuticals，Inc. Retinal Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Shire Plc
2.3.1 Business Overview
2.3.2 Retinal Pharmaceuticals Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Shire Plc Retinal Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Bayer AG
2.4.1 Business Overview
2.4.2 Retinal Pharmaceuticals Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Bayer AG Retinal Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Novartis International AG
2.5.1 Business Overview
2.5.2 Retinal Pharmaceuticals Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Novartis International AG Retinal Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Valeant Pharmaceuticals International，Inc
2.6.1 Business Overview
2.6.2 Retinal Pharmaceuticals Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Valeant Pharmaceuticals International，Inc Retinal Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Merck＆Co.
2.7.1 Business Overview
2.7.2 Retinal Pharmaceuticals Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Merck＆Co. Retinal Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Retinal Pharmaceuticals Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Retinal Pharmaceuticals Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Retinal Pharmaceuticals Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Retinal Pharmaceuticals Manufacturer Market Share in 2018
3.3.2 Top 6 Retinal Pharmaceuticals Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Retinal Pharmaceuticals Market Analysis by Regions
4.1 Global Retinal Pharmaceuticals Sales, Revenue and Market Share by Regions
4.1.1 Global Retinal Pharmaceuticals Sales and Market Share by Regions (2014-2019)
4.1.2 Global Retinal Pharmaceuticals Revenue and Market Share by Regions (2014-2019)
4.2 North America Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
4.3 Europe Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
4.5 South America Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
5 North America Retinal Pharmaceuticals by Country
5.1 North America Retinal Pharmaceuticals Sales, Revenue and Market Share by Country
5.1.1 North America Retinal Pharmaceuticals Sales and Market Share by Country (2014-2019)
5.1.2 North America Retinal Pharmaceuticals Revenue and Market Share by Country (2014-2019)
5.2 United States Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
5.3 Canada Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
5.4 Mexico Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
6 Europe Retinal Pharmaceuticals by Country
6.1 Europe Retinal Pharmaceuticals Sales, Revenue and Market Share by Country
6.1.1 Europe Retinal Pharmaceuticals Sales and Market Share by Country (2014-2019)
6.1.2 Europe Retinal Pharmaceuticals Revenue and Market Share by Country (2014-2019)
6.2 Germany Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
6.3 UK Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
6.4 France Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
6.5 Russia Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
6.6 Italy Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
7 Asia-Pacific Retinal Pharmaceuticals by Country
7.1 Asia-Pacific Retinal Pharmaceuticals Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Retinal Pharmaceuticals Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Retinal Pharmaceuticals Revenue and Market Share by Country (2014-2019)
7.2 China Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
7.3 Japan Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
7.4 Korea Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
7.5 India Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
8 South America Retinal Pharmaceuticals by Country
8.1 South America Retinal Pharmaceuticals Sales, Revenue and Market Share by Country
8.1.1 South America Retinal Pharmaceuticals Sales and Market Share by Country (2014-2019)
8.1.2 South America Retinal Pharmaceuticals Revenue and Market Share by Country (2014-2019)
8.2 Brazil Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
8.3 Argentina Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
8.4 Colombia Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
9 Middle East and Africa Retinal Pharmaceuticals by Countries
9.1 Middle East and Africa Retinal Pharmaceuticals Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Retinal Pharmaceuticals Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Retinal Pharmaceuticals Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
9.3 Turkey Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
9.4 Egypt Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
9.5 Nigeria Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
9.6 South Africa Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
10 Global Retinal Pharmaceuticals Market Segment by Type
10.1 Global Retinal Pharmaceuticals Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Retinal Pharmaceuticals Sales and Market Share by Type (2014-2019)
10.1.2 Global Retinal Pharmaceuticals Revenue and Market Share by Type (2014-2019)
10.2 Macular Degeneration Sales Growth and Price
10.2.1 Global Macular Degeneration Sales Growth (2014-2019)
10.2.2 Global Macular Degeneration Price (2014-2019)
10.3 Diabetic Eye Disease Sales Growth and Price
10.3.1 Global Diabetic Eye Disease Sales Growth (2014-2019)
10.3.2 Global Diabetic Eye Disease Price (2014-2019)
10.4 Retinal Detachment Sales Growth and Price
10.4.1 Global Retinal Detachment Sales Growth (2014-2019)
10.4.2 Global Retinal Detachment Price (2014-2019)
10.5 Retinoblastoma Sales Growth and Price
10.5.1 Global Retinoblastoma Sales Growth (2014-2019)
10.5.2 Global Retinoblastoma Price (2014-2019)
10.6 Macular Pucker Sales Growth and Price
10.6.1 Global Macular Pucker Sales Growth (2014-2019)
10.6.2 Global Macular Pucker Price (2014-2019)
10.7 Macular Hole Sales Growth and Price
10.7.1 Global Macular Hole Sales Growth (2014-2019)
10.7.2 Global Macular Hole Price (2014-2019)
10.8 Others Sales Growth and Price
10.8.1 Global Others Sales Growth (2014-2019)
10.8.2 Global Others Price (2014-2019)
11 Global Retinal Pharmaceuticals Market Segment by Application
11.1 Global Retinal Pharmaceuticals Sales Market Share by Application (2014-2019)
11.2 Hospital Pharmacies Sales Growth (2014-2019)
11.3 Online Pharmacies Sales Growth (2014-2019)
11.4 Independent Pharmacies Sales Growth (2014-2019)
12 Retinal Pharmaceuticals Market Forecast (2019-2024)
12.1 Global Retinal Pharmaceuticals Sales, Revenue and Growth Rate (2019-2024)
12.2 Retinal Pharmaceuticals Market Forecast by Regions (2019-2024)
12.2.1 North America Retinal Pharmaceuticals Market Forecast (2019-2024)
12.2.2 Europe Retinal Pharmaceuticals Market Forecast (2019-2024)
12.2.3 Asia-Pacific Retinal Pharmaceuticals Market Forecast (2019-2024)
12.2.4 South America Retinal Pharmaceuticals Market Forecast (2019-2024)
12.2.5 Middle East and Africa Retinal Pharmaceuticals Market Forecast (2019-2024)
12.3 Retinal Pharmaceuticals Market Forecast by Type (2019-2024)
12.3.1 Global Retinal Pharmaceuticals Sales Forecast by Type (2019-2024)
12.3.2 Global Retinal Pharmaceuticals Market Share Forecast by Type (2019-2024)
12.4 Retinal Pharmaceuticals Market Forecast by Application (2019-2024)
12.4.1 Global Retinal Pharmaceuticals Sales Forecast by Application (2019-2024)
12.4.2 Global Retinal Pharmaceuticals Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Retinal Pharmaceuticals Picture
Table Product Specifications of Retinal Pharmaceuticals
Figure Global Sales Market Share of Retinal Pharmaceuticals by Types in 2018
Table Retinal Pharmaceuticals Types for Major Manufacturers
Figure Macular Degeneration Picture
Figure Diabetic Eye Disease Picture
Figure Retinal Detachment Picture
Figure Retinoblastoma Picture
Figure Macular Pucker Picture
Figure Macular Hole Picture
Figure Others Picture
Figure Retinal Pharmaceuticals Sales Market Share by Applications in 2018
Figure Hospital Pharmacies Picture
Figure Online Pharmacies Picture
Figure Independent Pharmacies Picture
Figure United States Retinal Pharmaceuticals Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Retinal Pharmaceuticals Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Retinal Pharmaceuticals Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Retinal Pharmaceuticals Revenue (Value) and Growth Rate (2014-2024)
Figure France Retinal Pharmaceuticals Revenue (Value) and Growth Rate (2014-2024)
Figure UK Retinal Pharmaceuticals Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Retinal Pharmaceuticals Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Retinal Pharmaceuticals Revenue (Value) and Growth Rate (2014-2024)
Figure China Retinal Pharmaceuticals Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Retinal Pharmaceuticals Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Retinal Pharmaceuticals Revenue (Value) and Growth Rate (2014-2024)
Figure India Retinal Pharmaceuticals Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Retinal Pharmaceuticals Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Retinal Pharmaceuticals Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Retinal Pharmaceuticals Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Retinal Pharmaceuticals Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Retinal Pharmaceuticals Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Retinal Pharmaceuticals Revenue (Value) and Growth Rate (2014-2024)
Table Santen Pharmaceutical Co.，Ltd. Basic Information, Manufacturing Base and Competitors
Table Santen Pharmaceutical Co.，Ltd. Retinal Pharmaceuticals Type and Applications
Table Santen Pharmaceutical Co.，Ltd. Retinal Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Regeneron Pharmaceuticals，Inc. Basic Information, Manufacturing Base and Competitors
Table Regeneron Pharmaceuticals，Inc. Retinal Pharmaceuticals Type and Applications
Table Regeneron Pharmaceuticals，Inc. Retinal Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Shire Plc Basic Information, Manufacturing Base and Competitors
Table Shire Plc Retinal Pharmaceuticals Type and Applications
Table Shire Plc Retinal Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Bayer AG Basic Information, Manufacturing Base and Competitors
Table Bayer AG Retinal Pharmaceuticals Type and Applications
Table Bayer AG Retinal Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis International AG Basic Information, Manufacturing Base and Competitors
Table Novartis International AG Retinal Pharmaceuticals Type and Applications
Table Novartis International AG Retinal Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Valeant Pharmaceuticals International，Inc Basic Information, Manufacturing Base and Competitors
Table Valeant Pharmaceuticals International，Inc Retinal Pharmaceuticals Type and Applications
Table Valeant Pharmaceuticals International，Inc Retinal Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Merck＆Co. Basic Information, Manufacturing Base and Competitors
Table Merck＆Co. Retinal Pharmaceuticals Type and Applications
Table Merck＆Co. Retinal Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Retinal Pharmaceuticals Sales by Manufacturer (2017-2018)
Figure Global Retinal Pharmaceuticals Sales Market Share by Manufacturer in 2017
Figure Global Retinal Pharmaceuticals Sales Market Share by Manufacturer in 2018
Table Global Retinal Pharmaceuticals Revenue by Manufacturer (2017-2018)
Figure Global Retinal Pharmaceuticals Revenue Market Share by Manufacturer in 2017
Figure Global Retinal Pharmaceuticals Revenue Market Share by Manufacturer in 2018
Figure Top 3 Retinal Pharmaceuticals Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Retinal Pharmaceuticals Manufacturer (Revenue) Market Share in 2018
Figure Global Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
Figure Global Retinal Pharmaceuticals Revenue and Growth Rate (2014-2019)
Table Global Retinal Pharmaceuticals Sales by Regions (2014-2019)
Table Global Retinal Pharmaceuticals Sales Market Share by Regions (2014-2019)
Table Global Retinal Pharmaceuticals Revenue by Regions (2014-2019)
Figure Global Retinal Pharmaceuticals Revenue Market Share by Regions in 2014
Figure Global Retinal Pharmaceuticals Revenue Market Share by Regions in 2018
Figure North America Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
Figure Europe Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
Figure South America Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
Figure North America Retinal Pharmaceuticals Revenue and Growth Rate (2014-2019)
Table North America Retinal Pharmaceuticals Sales by Countries (2014-2019)
Table North America Retinal Pharmaceuticals Sales Market Share by Countries (2014-2019)
Figure North America Retinal Pharmaceuticals Sales Market Share by Countries in 2014
Figure North America Retinal Pharmaceuticals Sales Market Share by Countries in 2018
Table North America Retinal Pharmaceuticals Revenue by Countries (2014-2019)
Table North America Retinal Pharmaceuticals Revenue Market Share by Countries (2014-2019)
Figure North America Retinal Pharmaceuticals Revenue Market Share by Countries in 2014
Figure North America Retinal Pharmaceuticals Revenue Market Share by Countries in 2018
Figure United States Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
Figure Canada Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
Figure Mexico Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
Figure Europe Retinal Pharmaceuticals Revenue and Growth Rate (2014-2019)
Table Europe Retinal Pharmaceuticals Sales by Countries (2014-2019)
Table Europe Retinal Pharmaceuticals Sales Market Share by Countries (2014-2019)
Table Europe Retinal Pharmaceuticals Revenue by Countries (2014-2019)
Figure Europe Retinal Pharmaceuticals Revenue Market Share by Countries in 2017
Figure Europe Retinal Pharmaceuticals Revenue Market Share by Countries in 2018
Figure Germany Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
Figure UK Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
Figure France Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
Figure Russia Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
Figure Italy Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Retinal Pharmaceuticals Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Retinal Pharmaceuticals Sales by Countries (2014-2019)
Table Asia-Pacific Retinal Pharmaceuticals Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Retinal Pharmaceuticals Sales Market Share by Countries 2018
Table Asia-Pacific Retinal Pharmaceuticals Revenue by Countries (2014-2019)
Figure Asia-Pacific Retinal Pharmaceuticals Revenue Market Share by Countries 2018
Figure China Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
Figure Japan Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
Figure Korea Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
Figure India Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
Figure Southeast Asia Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
Figure South America Retinal Pharmaceuticals Revenue and Growth Rate (2014-2019)
Table South America Retinal Pharmaceuticals Sales by Countries (2014-2019)
Table South America Retinal Pharmaceuticals Sales Market Share by Countries (2014-2019)
Figure South America Retinal Pharmaceuticals Sales Market Share by Countries in 2018
Table South America Retinal Pharmaceuticals Revenue by Countries (2014-2019)
Table South America Retinal Pharmaceuticals Revenue Market Share by Countries (2014-2019)
Figure South America Retinal Pharmaceuticals Revenue Market Share by Countries in 2018
Figure Brazil Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
Figure Argentina Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
Figure Colombia Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Retinal Pharmaceuticals Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Retinal Pharmaceuticals Sales by Countries (2014-2019)
Table Middle East and Africa Retinal Pharmaceuticals Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Retinal Pharmaceuticals Sales Market Share by Countries in 2018
Table Middle East and Africa Retinal Pharmaceuticals Revenue by Countries (2014-2019)
Table Middle East and Africa Retinal Pharmaceuticals Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Retinal Pharmaceuticals Revenue Market Share by Countries in 2014
Figure Middle East and Africa Retinal Pharmaceuticals Revenue Market Share by Countries in 2018
Figure Saudi Arabia Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
Figure UAE Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
Figure Egypt Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
Figure Nigeria Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
Figure South Africa Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
Table Global Retinal Pharmaceuticals Sales by Type (2014-2019)
Table Global Retinal Pharmaceuticals Sales Share by Type (2014-2019)
Table Global Retinal Pharmaceuticals Revenue by Type (2014-2019)
Table Global Retinal Pharmaceuticals Revenue Share by Type (2014-2019)
Figure Global Macular Degeneration Sales Growth (2014-2019)
Figure Global Macular Degeneration Price (2014-2019)
Figure Global Diabetic Eye Disease Sales Growth (2014-2019)
Figure Global Diabetic Eye Disease Price (2014-2019)
Figure Global Retinal Detachment Sales Growth (2014-2019)
Figure Global Retinal Detachment Price (2014-2019)
Figure Global Retinoblastoma Sales Growth (2014-2019)
Figure Global Retinoblastoma Price (2014-2019)
Figure Global Macular Pucker Sales Growth (2014-2019)
Figure Global Macular Pucker Price (2014-2019)
Figure Global Macular Hole Sales Growth (2014-2019)
Figure Global Macular Hole Price (2014-2019)
Figure Global Others Sales Growth (2014-2019)
Figure Global Others Price (2014-2019)
Table Global Retinal Pharmaceuticals Sales by Application (2014-2019)
Table Global Retinal Pharmaceuticals Sales Share by Application (2014-2019)
Figure Global Online Pharmacies Sales Growth (2014-2019)
Figure Global Independent Pharmacies Sales Growth (2014-2019)
Figure Global Retinal Pharmaceuticals Sales, Revenue and Growth Rate (2019-2024)
Table Global Retinal Pharmaceuticals Sales Forecast by Regions (2019-2024)
Table Global Retinal Pharmaceuticals Market Share Forecast by Regions (2019-2024)
Figure North America Sales Retinal Pharmaceuticals Market Forecast (2019-2024)
Figure Europe Sales Retinal Pharmaceuticals Market Forecast (2019-2024)
Figure Asia-Pacific Sales Retinal Pharmaceuticals Market Forecast (2019-2024)
Figure South America Sales Retinal Pharmaceuticals Market Forecast (2019-2024)
Figure Middle East and Africa Sales Retinal Pharmaceuticals Market Forecast (2019-2024)
Table Global Retinal Pharmaceuticals Sales Forecast by Type (2019-2024)
Table Global Retinal Pharmaceuticals Market Share Forecast by Type (2019-2024)
Table Global Retinal Pharmaceuticals Sales Forecast by Application (2019-2024)
Table Global Retinal Pharmaceuticals Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
世界の黄斑変性症治療市場予測（～2024年） Macular degeneration, also known as age-related macular degeneration (AMD or ARMD), is a medical condition which may result in blurred or no vision in the center of the visual field. Early on there are often no symptoms. Over time, however, some people experience a gradual worsening of vision that m…- 世界の網膜イメージング装置市場予測（～2024年） Retinal Imaging Device provides simultaneous non-contact pole-to-periphery views of the retina in a single, patient-friendly capture. In this report include OCT and Fundus camera. Optical coherence tomography (OCT) is an imaging technique that uses low-coherence light to capture micrometer-resolutio…
- 世界の珍炎症性疾患市場予測（～2024年） Scope of the Report: The global Rare Inflammatory Disease Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially…
- 世界の海洋由来医薬品市場予測（～2024年） Marine derived pharmaceuticals are drugs and other pharmacological substances which are made from extracting elements present in marine organisms. Marine organisms are particularly attractive because they conform to traditional drug "models" of natural product drug sources. In addition, supply of bu…
- 世界のペメトレキセド市場予測（～2024年） Pemetrexed (brand name Alimta) is a chemotherapy drug manufactured and marketed by Eli Lilly and Company. Its indications are the treatment of pleural mesothelioma and non-small cell lung cancer. Scope of the Report: The worldwide market for Pemetrexed is expected to grow at a CAGR of roughly xx% ov…